FLIBANSERIN

FLIBANSERIN was reported 2007 times

FLIBANSERIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PES ANSERINUS SYNDROME 1 0.3333
1 SOCIAL ALCOHOL DRINKER 1 0.1667
2 LIVING ALONE 1 0.0333
3 CLAUDICATION OF JAW MUSCLES 1 0.0167
4 OESTRADIOL ABNORMAL 1 0.0152
5 DECORTICATE POSTURE 1 0.0089
6 SICK LEAVE 2 0.0089
7 SUSPECTED SUICIDE ATTEMPT 4 0.0067
8 DRUG TITRATION 1 0.0064
9 SALIVARY HYPOSECRETION 1 0.0062
10 FEMALE ORGASMIC DISORDER 2 0.0060
11 NEUROTRANSMITTER LEVEL ALTERED 1 0.0053
12 BREAST INDURATION 1 0.0052
13 PERSISTENT GENITAL AROUSAL DISORDER 1 0.0043
14 NIPPLE SWELLING 1 0.0040
15 LACK OF SATIETY 1 0.0038
16 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
17 BURSA DISORDER 1 0.0034
18 BREAST INFLAMMATION 1 0.0032
19 FEELING DRUNK 23 0.0031
20 PLASTIC SURGERY 1 0.0031
21 MIDDLE INSOMNIA 56 0.0030
22 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 19 0.0028
23 LOWER URINARY TRACT SYMPTOMS 1 0.0028
24 ORGASMIC SENSATION DECREASED 1 0.0026
25 SENSATION OF BLOOD FLOW 1 0.0026
26 HANGOVER 9 0.0026
27 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
28 VULVOVAGINAL RASH 1 0.0023
29 ORBITAL OEDEMA 1 0.0020
30 POSTURING 1 0.0019
31 INFANTILE SPITTING UP 1 0.0019
32 VESTIBULAR NEURONITIS 1 0.0019
33 AUTOSCOPY 1 0.0019
34 REPETITIVE SPEECH 1 0.0018
35 FLASHBACK 1 0.0017
36 TERMINAL INSOMNIA 3 0.0017
37 PERNICIOUS ANAEMIA 1 0.0016
38 OEDEMA GENITAL 1 0.0016
39 LIBIDO INCREASED 3 0.0015
40 INGROWN HAIR 1 0.0014
41 TACHYPHRENIA 5 0.0014
42 ELECTRIC SHOCK SENSATION 4 0.0014
43 BLUNTED AFFECT 1 0.0014
44 ALCOHOL USE 5 0.0014
45 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
46 DIZZINESS EXERTIONAL 1 0.0013
47 ADVERSE REACTION 17 0.0013
48 EXPOSURE VIA BODY FLUID 1 0.0013
49 THERAPEUTIC RESPONSE UNEXPECTED 56 0.0012
50 ORGASM ABNORMAL 1 0.0012
51 VULVOVAGINAL DRYNESS 4 0.0012
52 SLOW SPEECH 3 0.0012
53 LIP PRURITUS 1 0.0012
54 TONGUE PRURITUS 1 0.0012
55 OESOPHAGEAL OBSTRUCTION 1 0.0012
56 ADVERSE DRUG REACTION 100 0.0011
57 PRESYNCOPE 27 0.0011
58 PELVIC DISCOMFORT 1 0.0011
59 IMPAIRED DRIVING ABILITY 12 0.0011
60 VASCULAR PAIN 1 0.0010
61 MOTION SICKNESS 2 0.0010
62 HYPERVIGILANCE 1 0.0010
63 CARDIAC DISCOMFORT 2 0.0010
64 PSYCHOTIC BEHAVIOUR 1 0.0010
65 NIPPLE PAIN 2 0.0010
66 THERAPEUTIC RESPONSE CHANGED 6 0.0009
67 SLEEP DEFICIT 2 0.0009
68 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50 0.0009
69 INTERMENSTRUAL BLEEDING 5 0.0009
70 REACTION TO EXCIPIENT 2 0.0009
71 SURGICAL FAILURE 1 0.0009
72 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
73 INTRUSIVE THOUGHTS 1 0.0008
74 SOMNOLENCE 168 0.0008
75 BLADDER DISCOMFORT 1 0.0008
76 VAGINAL ODOUR 1 0.0008
77 LIBIDO DISORDER 1 0.0008
78 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
79 BREAST SWELLING 2 0.0007
80 INTENTIONAL DOSE OMISSION 21 0.0007
81 PREMENSTRUAL SYNDROME 1 0.0007
82 CHRONIC FATIGUE SYNDROME 1 0.0007
83 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
84 SLEEP TERROR 3 0.0007
85 NAIL INFECTION 1 0.0007
86 INITIAL INSOMNIA 7 0.0007
87 DIZZINESS 332 0.0007
88 ASTIGMATISM 1 0.0007
89 DYSPAREUNIA 3 0.0007
90 COITAL BLEEDING 1 0.0006
91 BACTERIAL VAGINOSIS 1 0.0006
92 PRODUCT USE IN UNAPPROVED INDICATION 154 0.0006
93 MENSTRUAL DISORDER 5 0.0006
94 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
95 SEIZURE LIKE PHENOMENA 1 0.0006
96 POLYMENORRHOEA 2 0.0006
97 SPONDYLOLISTHESIS 1 0.0006
98 BRAIN FOG 9 0.0006
99 DEPRESSIVE SYMPTOM 2 0.0006
100 VERTIGO 34 0.0006
101 HEAVY MENSTRUAL BLEEDING 5 0.0006
102 MOOD ALTERED 15 0.0005
103 METAMORPHOPSIA 1 0.0005
104 TUNNEL VISION 1 0.0005
105 INSOMNIA 142 0.0005
106 IMPATIENCE 1 0.0005
107 LIP DISORDER 1 0.0005
108 MICTURITION URGENCY 6 0.0005
109 HYPOREFLEXIA 1 0.0005
110 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
111 ALCOHOL INTERACTION 1 0.0005
112 DECREASED INTEREST 3 0.0005
113 FOAMING AT MOUTH 1 0.0005
114 RESTLESS LEGS SYNDROME 9 0.0005
115 SLUGGISHNESS 5 0.0005
116 EUPHORIC MOOD 5 0.0005
117 CHANGE OF BOWEL HABIT 1 0.0005
118 MUSCLE FATIGUE 2 0.0005
119 ABNORMAL DREAMS 13 0.0005
120 BREAST PAIN 5 0.0005
121 DRY MOUTH 38 0.0005
122 TENSION HEADACHE 2 0.0005
123 EXOPHTHALMOS 1 0.0005
124 MENSTRUATION DELAYED 5 0.0005
125 CHAPPED LIPS 2 0.0005
126 DYSPHEMIA 2 0.0005
127 BLOOD PRESSURE DECREASED 29 0.0004
128 ORAL PRURITUS 1 0.0004
129 RESPIRATION ABNORMAL 3 0.0004
130 MENOPAUSAL SYMPTOMS 1 0.0004
131 DRUG INEFFECTIVE 563 0.0004
132 PRURITUS GENITAL 1 0.0004
133 FEELING ABNORMAL 101 0.0004
134 URINE FLOW DECREASED 1 0.0004
135 POOR QUALITY SLEEP 9 0.0004
136 WRONG DOSE 1 0.0004
137 NOCTURIA 5 0.0004
138 BREATH ODOUR 1 0.0004
139 SUFFOCATION FEELING 1 0.0004
140 BREAST TENDERNESS 3 0.0004
141 HEAD DISCOMFORT 7 0.0004
142 VULVOVAGINAL PRURITUS 2 0.0004
143 MENOPAUSE 1 0.0004
144 DRUG TITRATION ERROR 1 0.0004
145 ANGER 13 0.0004
146 SEDATION 10 0.0004
147 AREFLEXIA 1 0.0004
148 FRUSTRATION TOLERANCE DECREASED 3 0.0004
149 ANORGASMIA 1 0.0004
150 THERAPEUTIC RESPONSE DELAYED 1 0.0004
151 OESOPHAGEAL STENOSIS 1 0.0004
152 LIP PAIN 1 0.0003
153 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
154 DYSPNOEA AT REST 1 0.0003
155 ORTHOSTATIC HYPOTENSION 6 0.0003
156 NEGATIVE THOUGHTS 1 0.0003
157 ENERGY INCREASED 2 0.0003
158 ADVERSE EVENT 31 0.0003
159 PRODUCT USE ISSUE 63 0.0003
160 IRRITABILITY 20 0.0003
161 ACNE CYSTIC 1 0.0003
162 EMERGENCY CARE 1 0.0003
163 VULVOVAGINAL BURNING SENSATION 2 0.0003
164 IMPAIRED WORK ABILITY 7 0.0003
165 SLEEP DISORDER 23 0.0003
166 PALPITATIONS 37 0.0003
167 HYPERSOMNIA 9 0.0003
168 CARDIAC FLUTTER 2 0.0003
169 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
170 PHARYNGEAL SWELLING 3 0.0003
171 INFUSION SITE HAEMORRHAGE 1 0.0003
172 BREAST MASS 2 0.0003
173 VAGINAL DISCHARGE 3 0.0003
174 THROAT TIGHTNESS 8 0.0003
175 HYPOTENSION 58 0.0003
176 NIGHTMARE 10 0.0003
177 DEPRESSED MOOD 15 0.0003
178 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
179 SKIN WEEPING 1 0.0003
180 TONGUE DISORDER 2 0.0003
181 FOOD INTOLERANCE 1 0.0003
182 MIGRAINE 26 0.0003
183 HYPERACUSIS 1 0.0003
184 HYPOAESTHESIA ORAL 4 0.0003
185 SNORING 1 0.0003
186 AUTOIMMUNE THYROIDITIS 1 0.0003
187 COMMUNICATION DISORDER 1 0.0003
188 EMOTIONAL DISORDER 8 0.0003
189 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
190 LIMB DISCOMFORT 8 0.0003
191 PANIC DISORDER 1 0.0003
192 EPIGASTRIC DISCOMFORT 1 0.0003
193 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
194 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
195 OESOPHAGEAL PAIN 1 0.0003
196 NAUSEA 199 0.0003
197 HYPERPHAGIA 1 0.0003
198 ENURESIS 1 0.0002
199 GALLBLADDER OPERATION 1 0.0002
200 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
201 RESTLESSNESS 9 0.0002
202 HYPERAESTHESIA 2 0.0002
203 LETHARGY 14 0.0002
204 SOCIAL PROBLEM 1 0.0002
205 UNEVALUABLE EVENT 18 0.0002
206 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
207 HEPATIC PAIN 1 0.0002
208 SWELLING FACE 15 0.0002
209 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
210 MENSTRUATION IRREGULAR 6 0.0002
211 LOSS OF LIBIDO 2 0.0002
212 HEART RATE IRREGULAR 5 0.0002
213 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
214 SYNOVIAL CYST 1 0.0002
215 POLLAKIURIA 9 0.0002
216 PRODUCT DISTRIBUTION ISSUE 2 0.0002
217 ARTHRITIS INFECTIVE 1 0.0002
218 HUNGER 3 0.0002
219 COORDINATION ABNORMAL 3 0.0002
220 THINKING ABNORMAL 4 0.0002
221 WITHDRAWAL SYNDROME 9 0.0002
222 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
223 FEELING JITTERY 4 0.0002
224 ENDOMETRIOSIS 1 0.0002
225 HEADACHE 130 0.0002
226 MENTAL IMPAIRMENT 5 0.0002
227 DIZZINESS POSTURAL 2 0.0002
228 DYSSTASIA 6 0.0002
229 HORMONE LEVEL ABNORMAL 1 0.0002
230 DISTURBANCE IN ATTENTION 11 0.0002
231 DISORIENTATION 8 0.0002
232 INABILITY TO AFFORD MEDICATION 2 0.0002
233 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
234 DRY THROAT 2 0.0002
235 PERIPHERAL VASCULAR DISORDER 1 0.0002
236 TRISMUS 1 0.0002
237 ANXIETY 55 0.0002
238 PANIC ATTACK 7 0.0002
239 MALAISE 83 0.0002
240 MOOD SWINGS 6 0.0002
241 MOVEMENT DISORDER 6 0.0002
242 NIGHT SWEATS 6 0.0002
243 FEAR 5 0.0002
244 BRUXISM 1 0.0002
245 PHARYNGITIS STREPTOCOCCAL 2 0.0002
246 FATIGUE 142 0.0002
247 NONSPECIFIC REACTION 1 0.0002
248 ASTHENOPIA 1 0.0002
249 DENTAL CARIES 2 0.0002
250 LIP SWELLING 6 0.0002
251 STREPTOCOCCAL INFECTION 1 0.0002
252 FEELING COLD 5 0.0002
253 PERIORBITAL SWELLING 1 0.0002
254 NEUROLOGICAL SYMPTOM 1 0.0002
255 EXERCISE TOLERANCE DECREASED 1 0.0002
256 HYPERVENTILATION 1 0.0002
257 SKIN WARM 1 0.0002
258 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
259 COLD SWEAT 3 0.0002
260 BRADYKINESIA 1 0.0002
261 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
262 FEELING HOT 10 0.0002
263 MENISCUS INJURY 1 0.0002
264 HEART RATE INCREASED 16 0.0002
265 SWOLLEN TONGUE 5 0.0002
266 NASAL DRYNESS 1 0.0002
267 DERMATITIS ALLERGIC 2 0.0002
268 BLEPHAROSPASM 1 0.0002
269 ILLNESS 16 0.0002
270 DYSMENORRHOEA 2 0.0002
271 BALANCE DISORDER 13 0.0002
272 EYE MOVEMENT DISORDER 1 0.0001
273 HOT FLUSH 11 0.0001
274 HAIR GROWTH ABNORMAL 1 0.0001
275 EXTRASYSTOLES 1 0.0001
276 HEART RATE DECREASED 5 0.0001
277 DIVERTICULUM 1 0.0001
278 PRODUCT SUPPLY ISSUE 1 0.0001
279 SYNCOPE 14 0.0001
280 PARAESTHESIA ORAL 2 0.0001
281 ABDOMINAL DISCOMFORT 23 0.0001
282 APATHY 2 0.0001
283 UTERINE LEIOMYOMA 1 0.0001
284 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
285 SENSITIVE SKIN 1 0.0001
286 HYPERSENSITIVITY 25 0.0001
287 NERVOUSNESS 7 0.0001
288 DISCOMFORT 8 0.0001
289 DISSOCIATION 1 0.0001
290 MULTIPLE ALLERGIES 1 0.0001
291 AFFECTIVE DISORDER 1 0.0001
292 FURUNCLE 1 0.0001
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
294 LOSS OF CONSCIOUSNESS 16 0.0001
295 TACHYCARDIA 11 0.0001
296 PARAESTHESIA 19 0.0001
297 EXPIRED PRODUCT ADMINISTERED 4 0.0001
298 GAIT DISTURBANCE 23 0.0001
299 DEPRESSION 27 0.0001
300 FACIAL PARALYSIS 1 0.0001
301 UNRESPONSIVE TO STIMULI 3 0.0001
302 PARANOIA 2 0.0001
303 SKIN SWELLING 1 0.0001
304 VAGINAL HAEMORRHAGE 5 0.0001
305 SPEECH DISORDER 6 0.0001
306 PURPURA 1 0.0001
307 RESPIRATORY RATE INCREASED 1 0.0001
308 THIRST 2 0.0001
309 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
310 OROPHARYNGEAL DISCOMFORT 1 0.0001
311 VOMITING 52 0.0001
312 LIP DRY 1 0.0001
313 PELVIC PAIN 2 0.0001
314 CRYING 4 0.0001
315 VISION BLURRED 15 0.0001
316 FLANK PAIN 1 0.0001
317 DYSARTHRIA 4 0.0001
318 SPINAL DISORDER 1 0.0001
319 EYE INFLAMMATION 1 0.0001
320 INCREASED APPETITE 2 0.0001
321 SEROTONIN SYNDROME 2 0.0001
322 AFFECT LABILITY 1 0.0001
323 EAR PAIN 2 0.0001
324 INTENTIONAL PRODUCT MISUSE 9 0.0001
325 PARKINSONISM 1 0.0001
326 HEPATOMEGALY 1 0.0001
327 THERAPY CHANGE 1 0.0001
328 URTICARIA 17 0.0001
329 BLOOD PRESSURE ABNORMAL 2 0.0001
330 APHASIA 3 0.0001
331 EXTRA DOSE ADMINISTERED 4 0.0001
332 DYSKINESIA 4 0.0001
333 EAR DISCOMFORT 1 0.0001
334 TENDERNESS 1 0.0001
335 INCONTINENCE 1 0.0001
336 RENAL PAIN 1 0.0001
337 RETCHING 2 0.0001
338 HYPOAESTHESIA 14 0.0001
339 LIVER FUNCTION TEST INCREASED 2 0.0001
340 HYPERHIDROSIS 12 0.0001
341 ACNE 7 0.0001
342 SKIN LACERATION 1 0.0001
343 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
344 DRUG INTERACTION 14 0.0001
345 DERMATITIS CONTACT 1 0.0001
346 SCAB 1 0.0001
347 CHOLECYSTECTOMY 1 0.0001
348 TINNITUS 4 0.0001
349 MUSCLE TWITCHING 2 0.0001
350 CONFUSIONAL STATE 14 0.0001
351 TREMOR 14 0.0001
352 DYSPHAGIA 8 0.0001
353 ATAXIA 1 0.0001
354 THERAPY INTERRUPTED 6 0.0001
355 MYOCLONUS 1 0.0001
356 MUSCLE RIGIDITY 1 0.0001
357 AGITATION 6 0.0001
358 CHEST PAIN 15 0.0001
359 GENERALISED OEDEMA 1 0.0001
360 VISUAL IMPAIRMENT 10 0.0001
361 EYE SWELLING 3 0.0001
362 BRAIN OEDEMA 1 0.0001
363 ABDOMINAL PAIN LOWER 2 0.0001
364 CHEST DISCOMFORT 8 0.0001
365 MYDRIASIS 1 0.0001
366 SUICIDAL IDEATION 7 0.0001
367 BEDRIDDEN 1 0.0001
368 TOOTH INFECTION 1 0.0001
369 RASH 33 0.0001
370 RASH PRURITIC 4 0.0001
371 PERIPHERAL COLDNESS 1 0.0001
372 DRUG INTOLERANCE 7 0.0001
373 ORAL DISCOMFORT 1 0.0001
374 BLOOD PRESSURE INCREASED 11 0.0001
375 CARPAL TUNNEL SYNDROME 1 0.0001
376 BLOOD TEST ABNORMAL 1 0.0001
377 SKIN REACTION 1 0.0001
378 SINUS TACHYCARDIA 1 0.0001
379 HYPERTHYROIDISM 1 0.0001
380 MENTAL DISORDER 3 0.0001
381 HYPOKINESIA 1 0.0001
382 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
383 SKIN HAEMORRHAGE 1 0.0001
384 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
385 THERAPEUTIC RESPONSE DECREASED 4 0.0001
386 OSTEOPENIA 1 0.0001
387 DRUG DISPENSING ERROR 1 0.0001
388 INSURANCE ISSUE 1 0.0001
389 PRODUCT DOSE OMISSION ISSUE 19 0.0001
390 DELUSION 1 0.0001
391 SWELLING 6 0.0001
392 THERAPY PARTIAL RESPONDER 1 0.0001
393 PRODUCT USE COMPLAINT 1 0.0001
394 HEAD INJURY 2 0.0001
395 MUSCLE TIGHTNESS 1 0.0001
396 BACK DISORDER 1 0.0001
397 ASTHENIA 23 0.0001
398 MANIA 1 0.0001
399 DRY EYE 3 0.0001
400 EYE PRURITUS 2 0.0001
401 FACE OEDEMA 1 0.0001
402 HEMIPARESIS 1 0.0001
403 METRORRHAGIA 1 0.0001
404 THERAPY CESSATION 3 0.0001
405 ABDOMINAL DISTENSION 6 0.0001
406 ECZEMA 3 0.0001
407 BURNING SENSATION 4 0.0001
408 HYPERTENSION 12 0.0001
409 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
410 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
411 MOBILITY DECREASED 4 0.0001
412 TOOTHACHE 1 0.0001
413 ACCIDENTAL OVERDOSE 2 0.0001
414 MEDICATION ERROR 3 0.0001
415 ABDOMINAL PAIN UPPER 11 0.0001
416 PHOTOPHOBIA 1 0.0001
417 FLATULENCE 3 0.0001
418 POST PROCEDURAL COMPLICATION 1 0.0001
419 DRUG PRESCRIBING ERROR 1 0.0001
420 CONTUSION 5 0.0001
421 PERIPHERAL SWELLING 8 0.0001
422 PRESCRIBED OVERDOSE 1 0.0001
423 CHOKING 1 0.0001
424 ORAL HERPES 1 0.0001
425 ABNORMAL BEHAVIOUR 2 0.0001
426 COMPLICATION OF DEVICE INSERTION 1 0.0001
427 PRESCRIBED UNDERDOSE 1 0.0001
428 PRODUCT PHYSICAL ISSUE 1 0.0000
429 PRURITUS 19 0.0000
430 DYSPNOEA 27 0.0000
431 IRRITABLE BOWEL SYNDROME 1 0.0000
432 DEVICE EXPULSION 3 0.0000
433 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
434 THROAT IRRITATION 2 0.0000
435 THERAPY NON-RESPONDER 2 0.0000
436 CHROMATURIA 1 0.0000
437 ERYTHEMA 9 0.0000
438 MEMORY IMPAIRMENT 6 0.0000
439 MUSCLE SPASMS 8 0.0000
440 WEIGHT DECREASED 12 0.0000
441 COGNITIVE DISORDER 2 0.0000
442 CHILLS 5 0.0000
443 OCULAR HYPERAEMIA 2 0.0000
444 PRODUCT PRESCRIBING ERROR 1 0.0000
445 RASH ERYTHEMATOUS 2 0.0000
446 JOINT SWELLING 5 0.0000
447 INJECTION SITE URTICARIA 1 0.0000
448 PNEUMONIA ASPIRATION 1 0.0000
449 AGGRESSION 2 0.0000
450 FLUSHING 4 0.0000
451 ERECTILE DYSFUNCTION 1 0.0000
452 SKIN ULCER 1 0.0000
453 JOINT STIFFNESS 1 0.0000
454 ANHEDONIA 1 0.0000
455 GASTRITIS 1 0.0000
456 EAR INFECTION 1 0.0000
457 DRY SKIN 5 0.0000
458 FREQUENT BOWEL MOVEMENTS 1 0.0000
459 PALLOR 1 0.0000
460 TREATMENT NONCOMPLIANCE 2 0.0000
461 SKIN LESION 1 0.0000
462 INFLUENZA LIKE ILLNESS 3 0.0000
463 DRUG DOSE OMISSION 6 0.0000
464 PAIN IN JAW 1 0.0000
465 HERPES ZOSTER 2 0.0000
466 SEIZURE 4 0.0000
467 SURGERY 2 0.0000
468 NASAL CONGESTION 2 0.0000
469 URINARY INCONTINENCE 1 0.0000
470 LACRIMATION INCREASED 1 0.0000
471 FALL 11 0.0000
472 DRUG ADMINISTRATION ERROR 1 0.0000
473 CONSTIPATION 7 0.0000
474 NERVOUS SYSTEM DISORDER 1 0.0000
475 DRUG-INDUCED LIVER INJURY 1 0.0000
476 PYREXIA 11 0.0000
477 HYPOTHYROIDISM 1 0.0000
478 AMNESIA 2 0.0000
479 DYSPEPSIA 3 0.0000
480 FUNGAL INFECTION 1 0.0000
481 SKIN DISORDER 1 0.0000
482 URINARY RETENTION 1 0.0000
483 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
484 CONDITION AGGRAVATED 9 0.0000
485 MYALGIA 5 0.0000
486 GASTRIC DISORDER 1 0.0000
487 RASH MACULAR 1 0.0000
488 COVID-19 5 0.0000
489 CEREBRAL HAEMORRHAGE 1 0.0000
490 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
491 NO ADVERSE EVENT 5 0.0000
492 DRUG EFFECT INCOMPLETE 1 0.0000
493 DYSURIA 1 0.0000
494 WEIGHT INCREASED 6 0.0000
495 HALLUCINATION 2 0.0000
496 RHEUMATOID ARTHRITIS 3 0.0000
497 MUSCULAR WEAKNESS 3 0.0000
498 COLITIS 1 0.0000
499 DECREASED APPETITE 6 0.0000
500 ABDOMINAL PAIN 6 0.0000
501 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
502 DIARRHOEA 16 0.0000
503 SKIN EXFOLIATION 2 0.0000
504 OSTEOARTHRITIS 1 0.0000
505 RECTAL HAEMORRHAGE 1 0.0000
506 LIVER DISORDER 1 0.0000
507 DEHYDRATION 3 0.0000
508 SKIN DISCOLOURATION 1 0.0000
509 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
510 BACK PAIN 5 0.0000
511 RENAL DISORDER 1 0.0000
512 COUGH 6 0.0000
513 BLOOD GLUCOSE DECREASED 1 0.0000
514 ALOPECIA 4 0.0000
515 CELLULITIS 1 0.0000
516 SINUSITIS 2 0.0000
517 INFLAMMATION 1 0.0000
518 BRADYCARDIA 1 0.0000
519 OEDEMA 1 0.0000
520 ANAPHYLACTIC REACTION 1 0.0000
521 ARTHROPATHY 1 0.0000
522 NECK PAIN 1 0.0000
523 BLISTER 1 0.0000
524 OXYGEN SATURATION DECREASED 1 0.0000
525 CEREBROVASCULAR ACCIDENT 3 0.0000
526 ASTHMA 2 0.0000
527 URINARY TRACT INFECTION 3 0.0000
528 EYE IRRITATION 1 0.0000
529 PRODUCT SUBSTITUTION ISSUE 1 0.0000
530 MYOCARDIAL INFARCTION 3 0.0000
531 DYSPHONIA 1 0.0000
532 CATARACT 1 0.0000
533 SUICIDE ATTEMPT 1 0.0000
534 PAIN 10 0.0000
535 EXPOSURE DURING PREGNANCY 1 0.0000
536 NEOPLASM MALIGNANT 1 0.0000
537 INJECTION SITE PRURITUS 1 0.0000
538 HEPATIC ENZYME INCREASED 1 0.0000
539 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
540 SKIN BURNING SENSATION 1 0.0000
541 RESPIRATORY FAILURE 1 0.0000
542 OFF LABEL USE 12 0.0000
543 PAIN IN EXTREMITY 4 0.0000
544 DYSGEUSIA 1 0.0000
545 EPISTAXIS 1 0.0000
546 INCORRECT DOSE ADMINISTERED 3 0.0000
547 DIABETES MELLITUS 1 0.0000
548 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
549 TREATMENT FAILURE 1 0.0000
550 ARTHRALGIA 5 0.0000
551 PRODUCT STORAGE ERROR 1 0.0000
552 DRUG WITHDRAWAL SYNDROME 1 0.0000
553 GASTROINTESTINAL DISORDER 1 0.0000
554 NASOPHARYNGITIS 2 0.0000
555 BREAST CANCER 1 0.0000
556 ATRIAL FIBRILLATION 1 0.0000
557 HAEMORRHAGE 1 0.0000
558 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
559 INFLUENZA 1 0.0000
560 EMOTIONAL DISTRESS 1 0.0000
561 OEDEMA PERIPHERAL 1 0.0000
562 INJECTION SITE ERYTHEMA 1 0.0000
563 PRODUCT QUALITY ISSUE 1 0.0000
564 INFECTION 1 0.0000
565 HOSPITALISATION 1 0.0000
566 TOXICITY TO VARIOUS AGENTS 1 0.0000
567 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
568 INJECTION SITE PAIN 1 0.0000